We use cookies to make this site work. We'd also like to set optional cookies so we can understand how the site is used and improve it. We will not set optional cookies unless you accept them. You can change your choice at any time from the Cookie settings link in the footer.
Strictly necessary cookies
These cookies are required for the site to work. They store your cookie preferences and keep your session secure. They are exempt from consent under PECR Regulation 6(4) because they are essential to deliver the service you have requested.
Optional cookies
Optional cookies help us understand how the site is used and provide additional features such as analytics, accessibility tools and translation. We will only set them if you accept.
NHS respiratory syncytial virus (RSV) vaccine
All adults aged 80 and over, and people living in a care home for older adults, are now eligible for the NHS respiratory syncytial virus (RSV) vaccine, following the expansion of the vaccination programme to around 3 million more people.
RSV is a common virus that infects the lungs. While symptoms are mild for many people, the virus can be severe in older adults, causing pneumonia, bronchitis and flare-ups of existing lung disease and other long-term conditions. This can make it difficult to breathe and leave some older people requiring hospital treatment.
RSV causes around 9,000 hospitalisations in those aged over 75 in the UK each year, but a single dose of the vaccine provides protection for several years.
The vaccine can be booked via your GP practice, by speaking to staff in care homes and some community pharmacies in parts of England are also offering the RSV vaccine.
Published: Apr 13, 2026